Modern Diagnostic & Research Centre last traded at ₹65.00 (2026-10-13). Over the past month the stock moved +0.0%, three months the stock moved -8.5%. Its closing range over 52 weeks is ₹48.00 – ₹94.99, with the latest close 31.6% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1985, Modern Diagnostic & Research Centre Limited (MDRC) is a diagnostic chain in India, offering a comprehensive range of pathology and radiology services.[1]
Business Profile[1] Modern Diagnostic & Research Centre Limited is an integrated diagnostic services provider offering pathology and radiology services across India. The company operates a one-stop diagnostic model covering routine, high-end, and specialized tests for patients, hospitals, corporates, and healthcare providers.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 39.92 | 5.08 | 12.73 | 2.08 | 1.38 |
In the latest year (Mar 2026), Modern Diagnostic & Research Centre reported sales of ₹83.11 crore (+6.6%) and net profit of ₹5.25 crore (-41.5%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 83.11 | 12.59 | 15.15 | 5.25 | 3.48 |
| Mar 2025 | 77.95 | 17.96 | 23.04 | 8.97 | 8.15 |
| Mar 2024 | 67.13 | 11.14 | 16.59 | 5.79 | 57.90 |
| Mar 2023 | 56.28 | -0.98 | -1.74 | -5.73 | -57.30 |
| Mar 2022 | 60.21 | 6.02 | 10.00 | -1.45 | -14.50 |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales growth | -6.5% | +19.3% | +16.1% | +6.6% |
| Operating profit growth | -116.3% | – | +61.2% | -29.9% |
| Net profit growth | – | – | +54.9% | -41.5% |
| EPS growth | – | – | -85.9% | -57.3% |
| OPM % | -1.7% | 16.6% | 23.0% | 15.2% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Modern Diagnostic & Research Centre.
Get Free AI Stock Analysis FREE →Modern Diagnostic & Research Centre Board Approves Extension of IPO Proceeds Utilization and Working Capital Allocation - scanx.trade
Modern Diagnostic & Research Centre Board Approves Extension of IPO Proceeds Utilization and Working Capital Allocation - scanx.trade
Modern Diagnostic & Research Centre shares were last quoted at ₹65.00 (+0.5% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Modern Diagnostic & Research Centre has a price-to-earnings (P/E) ratio of 21.77 and a price-to-book (P/B) ratio of 1.95. The industry P/E is 101.02.
The 52-week high of Modern Diagnostic & Research Centre is ₹100.00 and the 52-week low is ₹45.00.
The market capitalisation of Modern Diagnostic & Research Centre is about ₹114.38 crore.
This page is for information and is not investment advice. As per the data shown here, Modern Diagnostic & Research Centre has a 3-year ROE of 31.00%, 3-year profit growth of 43.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 72.85% of Modern Diagnostic & Research Centre.
Modern Diagnostic & Research Centre belongs to the Labs & Life Sciences Services sector.
All Labs & Life Sciences Services stocks · Browse all stocks A–Z